4-76166254-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_005506.4(SCARB2):c.1235A>G(p.Asn412Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000753 in 1,461,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005506.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARB2 | NM_005506.4 | c.1235A>G | p.Asn412Ser | missense_variant | Exon 10 of 12 | ENST00000264896.8 | NP_005497.1 | |
SCARB2 | NM_001204255.2 | c.806A>G | p.Asn269Ser | missense_variant | Exon 7 of 9 | NP_001191184.1 | ||
SCARB2 | XM_047416429.1 | c.761A>G | p.Asn254Ser | missense_variant | Exon 10 of 12 | XP_047272385.1 | ||
SCARB2 | XM_047416430.1 | c.761A>G | p.Asn254Ser | missense_variant | Exon 10 of 12 | XP_047272386.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251402Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135866
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461538Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 727104
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 412 of the SCARB2 protein (p.Asn412Ser). This variant is present in population databases (rs771661901, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SCARB2-related conditions. ClinVar contains an entry for this variant (Variation ID: 462920). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at